PRE-CLINICAL CAPABILITIES

• Formulation development
• Clinical methods
• Monitoring device evaluation
• Translational science

CLINICAL RESEARCH CAPABILITIES

• PHASE I STUDIES
  • Bioavailability and Bioequivalence
  • Developmental pharmacogenetics
  • In-vitro characterization of drug metabolism using age-appropriate model system
  • In-vitro assessment of metabolite-mediated cellular injury
  • Pharmacogenomics in pediatric populations
  • Pharmacokinetics modeling
  • Pharmacodynamics
• PHASE II AND III STUDIES
  • Hospital inpatient studies (includes patients in neonatal intensive care units and pediatric intensive care units)
  • Inpatient ambulatory care studies
  • Special care unit
• PHASE IV STUDIES
  • Post-marketing study designs
• LABORATORY/ASSAY SPECIALIZATION
  • Small volume sample drug and metabolites analysis
  • Access to GLP laboratory analytical facilities.
  • Core molecular pharmacology and pharmacogenetic laboratory
  • Antiviral drugs assays
• PEDIATRIC SUBSPECIALTIES
  • Behavioral medicine
  • Cardiology
  • Endocrinology
  • Gastroenterology
  • Infectious diseases
  • Hematology
  • Hypertension
  • Immunology/allergy
  • Immunopharmacology
  • Metabolism
  • Neurology
  • Pain management
  • Oncology
  • Nephrology
  • Pulmonology
  • Psychiatry